


Cedilla Therapeutics
Biotechnology Research • Cambridge, Massachusetts, United States • 1-10 Employees
Company overview
| Headquarters | 245 First Street, 3rd Floor, Cambridge, Massachusetts 02142, US |
| Phone number | +16172815658 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotechnology, Medicine, Life Sciences, Science, Oncology, Team, Protein, Third Rock Ventures |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
Key Contact at Cedilla Therapeutics
Alan D'Andrea
Co-Founder
About Cedilla Therapeutics
For 60 years, sequence and structure has been the primary lens to understand protein function. It’s now time to look beyond and leverage the orchestration of protein function within cells. Cedilla Therapeutics is bringing a new dimension to precision oncology. We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking critical and elusive cancer targets including TEAD and CDK2. We are a driven and patient-focused team.
Cedilla Therapeutics revenue & valuation
| Annual revenue | $2,500,000 |
| Revenue per employee | $417,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $8,000,000 |
| Total funding | $25,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Cedilla Therapeutics has 3 employees across 2 departments.
Departments
Number of employees
Cedilla Therapeutics Tech Stack
Discover the technologies and tools that power Cedilla Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
Frequently asked questions
4.8
40,000 users



